Pemetrexed is a multi-targeted antifolate anti-cancer agent that inhibits TS, dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyl transferase (GARFT) [5,6]. The gene discussed is DHFR; the disease is cancer.